Orthocell Appoints MediTime as Exclusive Thai Distributor for Remplir Nerve Repair Product

MT Newswires Live

Jul 03

Orthocell (ASX:OCC) appointed MediTime as its exclusive in-country distributor for its nerve repair product Remplir in Thailand, according to a Friday Australian bourse filing.

The company said MediTime's clinical education platform, key opinion leader (KOL) relationships, hospital access, and logistics network are expected to accelerate the engagement and adoption of Remplir throughout Thailand.

The company added that the appointment further strengthens Orthocell's expanding Asian distribution network, with product sales underway in Australia, Singapore, and Hong Kong, while the company continues to focus resources on the US market, where recent approvals have expanded access to around 336 hospitals, including 221 US military medical centers.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/2648639224"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2648639224\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2648639224?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 07:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2648639224","market":"sh","top_or_hot":-1,"title":"Orthocell Appoints MediTime as Exclusive Thai Distributor for Remplir Nerve Repair Product","media":"MT Newswires Live","content":"<html><body><p> Orthocell (ASX:OCC) appointed MediTime as its exclusive in-country distributor for its nerve repair product Remplir in Thailand, according to a Friday Australian bourse filing.</p><p>The company said MediTime's clinical education platform, key opinion leader (KOL) relationships, hospital access, and logistics network are expected to accelerate the engagement and adoption of Remplir throughout Thailand.</p><p>The company added that the appointment further strengthens Orthocell's expanding Asian distribution network, with product sales underway in Australia, Singapore, and Hong Kong, while the company continues to focus resources on the US market, where recent approvals have expanded access to around 336 hospitals, including 221 US military medical centers.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orthocell Appoints MediTime as Exclusive Thai Distributor for Remplir Nerve Repair Product</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrthocell Appoints MediTime as Exclusive Thai Distributor for Remplir Nerve Repair Product\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-03 07:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Orthocell (ASX:OCC) appointed MediTime as its exclusive in-country distributor for its nerve repair product Remplir in Thailand, according to a Friday Australian bourse filing.</p><p>The company said MediTime's clinical education platform, key opinion leader (KOL) relationships, hospital access, and logistics network are expected to accelerate the engagement and adoption of Remplir throughout Thailand.</p><p>The company added that the appointment further strengthens Orthocell's expanding Asian distribution network, with product sales underway in Australia, Singapore, and Hong Kong, while the company continues to focus resources on the US market, where recent approvals have expanded access to around 336 hospitals, including 221 US military medical centers.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"医药生物股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2648639224","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2648639224","pubTimestamp":1783034968,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Orthocell  appointed MediTime as its exclusive in-country distributor for its nerve repair product Remplir in Thailand, according to a Friday Australian bourse filing.The company said MediTime's clinical education platform, key opinion leader  relationships, hospital access, and logistics network are expected to accelerate the engagement and adoption of Remplir throughout Thailand.The company added that the appointment further strengthens Orthocell's expanding Asian distribution network, with product sales underway in Australia, Singapore, and Hong Kong, while the company continues to focus resources on the US market, where recent approvals have expanded access to around 336 hospitals, including 221 US military medical centers.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","KOL":"Market Vectors-Coal ETF","BK7067":"生物科技","OCC.AU":"ORTHOCELL LTD"},"translate_title":"Orthocell任命MediTime为Remplir神经修复产品泰国独家经销商","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KOL":1,"OCC.AU":1},"content_text":"Orthocell (ASX:OCC) appointed MediTime as its exclusive in-country distributor for its nerve repair product Remplir in Thailand, according to a Friday Australian bourse filing.The company said MediTime's clinical education platform, key opinion leader (KOL) relationships, hospital access, and logistics network are expected to accelerate the engagement and adoption of Remplir throughout Thailand.The company added that the appointment further strengthens Orthocell's expanding Asian distribution network, with product sales underway in Australia, Singapore, and Hong Kong, while the company continues to focus resources on the US market, where recent approvals have expanded access to around 336 hospitals, including 221 US military medical centers.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}